Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010002 PGF2a cPLA2i 1.0 BCD110605C28 0.486 pmol/ml medium
LMFA03010002 PGF2a cPLA2i 1.0 BCD110605C30 0.577 pmol/ml medium
LMFA03010002 PGF2a cPLA2i 1.0 BCD110605C29 0.445 pmol/ml medium
LMFA03010002 PGF2a cPLA2i 20.0 BCD110605C64 0.317 pmol/ml medium
LMFA03010002 PGF2a cPLA2i 20.0 BCD110605C66 0.22 pmol/ml medium
LMFA03010002 PGF2a cPLA2i 20.0 BCD110605C65 0.458 pmol/ml medium
LMFA03010002 PGF2a PLDi 1.0 BCD110605C16 0.375 pmol/ml medium
LMFA03010002 PGF2a PLDi 1.0 BCD110605C17 0.313 pmol/ml medium
LMFA03010002 PGF2a PLDi 1.0 BCD110605C18 0.431 pmol/ml medium
LMFA03010002 PGF2a PLDi 20.0 BCD110605C54 0.349 pmol/ml medium
LMFA03010002 PGF2a PLDi 20.0 BCD110605C52 0.373 pmol/ml medium
LMFA03010002 PGF2a PLDi 20.0 BCD110605C53 0.528 pmol/ml medium
LMFA03010002 PGF2a KDO+cPLA2i 1.0 BCD110605C32 0.333 pmol/ml medium
LMFA03010002 PGF2a KDO+cPLA2i 1.0 BCD110605C31 0.36 pmol/ml medium
LMFA03010002 PGF2a KDO+cPLA2i 1.0 BCD110605C33 0.396 pmol/ml medium
LMFA03010002 PGF2a KDO+cPLA2i 20.0 BCD110605C68 0.383 pmol/ml medium
LMFA03010002 PGF2a KDO+cPLA2i 20.0 BCD110605C69 0.484 pmol/ml medium
LMFA03010002 PGF2a KDO+cPLA2i 20.0 BCD110605C67 0.591 pmol/ml medium
LMFA03010002 PGF2a KDO+PLDi 1.0 BCD110605C19 0.505 pmol/ml medium
LMFA03010002 PGF2a KDO+PLDi 1.0 BCD110605C20 0.365 pmol/ml medium
LMFA03010002 PGF2a KDO+PLDi 1.0 BCD110605C21 0.55 pmol/ml medium
LMFA03010002 PGF2a KDO+PLDi 20.0 BCD110605C56 0.327 pmol/ml medium
LMFA03010002 PGF2a KDO+PLDi 20.0 BCD110605C57 0.637 pmol/ml medium
LMFA03010002 PGF2a KDO+PLDi 20.0 BCD110605C55 0.548 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C37 0.244 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C38 0.312 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C39 0.48 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C74 0.597 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C75 0.816 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C73 0.631 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+PLDi 1.0 BCD110605C25 0.662 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+PLDi 1.0 BCD110605C27 0.613 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+PLDi 1.0 BCD110605C26 0.531 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+PLDi 20.0 BCD110605C61 0.932 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+PLDi 20.0 BCD110605C62 0.975 pmol/ml medium
LMFA03010002 PGF2a KDO+ATP+PLDi 20.0 BCD110605C63 1.37 pmol/ml medium
LMFA03010002 PGF2a KDO + ATP 1.0 BCD110605C15 0.465 pmol/ml medium
LMFA03010002 PGF2a KDO + ATP 1.0 BCD110605C14 0.363 pmol/ml medium
LMFA03010002 PGF2a KDO + ATP 1.0 BCD110605C13 0.46 pmol/ml medium
LMFA03010002 PGF2a KDO + ATP 20.0 BCD110605C49 1.17 pmol/ml medium
LMFA03010002 PGF2a KDO + ATP 20.0 BCD110605C50 0.837 pmol/ml medium
LMFA03010002 PGF2a KDO + ATP 20.0 BCD110605C51 1.19 pmol/ml medium
LMFA03010002 PGF2a KDO 1.0 BCD110605C08 0.592 pmol/ml medium
LMFA03010002 PGF2a KDO 1.0 BCD110605C07 0.61 pmol/ml medium
LMFA03010002 PGF2a KDO 1.0 BCD110605C09 0.217 pmol/ml medium
LMFA03010002 PGF2a KDO 20.0 BCD110605C45 0.554 pmol/ml medium
LMFA03010002 PGF2a KDO 20.0 BCD110605C44 0.435 pmol/ml medium
LMFA03010002 PGF2a KDO 20.0 BCD110605C43 0.344 pmol/ml medium
LMFA03010002 PGF2a C 0.0 BCD110605C03 0.542 pmol/ml medium
LMFA03010002 PGF2a C 0.0 BCD110605C01 0.534 pmol/ml medium